The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins
Published version of a preprint
Abstract
By expressing two genes (hTERT and Cdk4), we have developed a method to reproducibly generate continuously replicating human bronchial epithelial cell (HBEC) lines that provide a novel resource to study the molecular pathogenesis of lung cancer and the differentiation of bronchial epithelial cells. Twelve human bronchial epithelial biopsy specimens obtained from persons with and without lung cancer were placed into short-term culture and serially transfected with retroviral constructs containing cyclin-dependent kinase (Cdk) 4 and human telomerase reverse transcriptase (hTERT), resulting in continuously growing cultures. The order of introduction of Cdk4 and hTERT did not appear to be important; however, transfection of either gene alone did not result in immortalization. Although they could be cloned, the immortalized bronchial cells did not form colonies in soft agar or tumors in nude mice. The immortalized HBECs have epithelial morphology; express epithelial markers cytokeratins 7, 14, 17, and 19, the stem cell marker p63, and high levels of p16INK4a; and have an intact p53 checkpoint pathway. Cytogenetic analysis and array comparative genomic hybridization profiling show immortalized HBECs to have duplication of parts of chromosomes 5 and 20. Microarray gene expression profiling demonstrates that the Cdk4/hTERT-immortalized bronchial cell lines clustered together and with nonimmortalized bronchial cells, distinct from lung cancer cell lines. We also immortalized several parental cultures with viral oncoproteins human papilloma virus type 16 E6/E7 with and without hTERT, and these cells exhibited loss of the p53 checkpoint and significantly different gene expression profiles compared with Cdk4/hTERT-immortalized HBECs. These HBEC lines are a valuable new tool for studying of the pathogenesis of lung cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CDK4 expression, along with increased hTERT gene expression, has been used for the immortalization of human bronchial epithelial cells [98].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [98]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444 · cited 5×
“We reported previously that premature growth arrest in epidermal keratinocytes and human mammary epithelial cells when cultivated in vitro was associated with up-regulation of the cyclin-dependent kinase (Cdk) inhibitor, p16 (9, 10).”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 26
- Reddel RR, Ke Y, Gerwin BI, et al Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48: 1904-9.
- Reddel RR, Salghetti SE, Willey JC, et al Development of tumorigenicity in simian virus 40-immortalized human bronchial epithelial cell lines. Cancer Res 1993; 53: 985-91.
- Lundberg AS, Randell SH, Stewart SA, et al Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene 2002; 21: 4577-86. · DOI
- Harley CB Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991; 256: 271-82. · DOI · Paper page
- Harley CB, Vaziri H, Counter CM, Allsopp RC The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27: 375-82. · DOI
- Shay JW, Werbin H, Wright WE Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Differ 1994; 2: 1-18.
- Wright WE, Pereira-Smith OM, Shay JW Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989; 9: 3088-92. · DOI
- Herbert BS, Wright WE, Shay JW p16INK4a inactivation is not required to immortalize human mammary epithelial cells. Oncogene 2002; 21: 7897-900. · DOI
- Ramirez RD, Herbert BS, Vaughan MB, et al Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells. Oncogene 2003; 22: 433-44. · DOI
- Miller AD, Rosman GJ Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-6, 989.
- Piatyszek MA, Kim NW, et al Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995; 17: 1-15. · DOI
- Wright WE, Shay JW, Piatyszek MA Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-5. · DOI
- Herrmann BG, Frischauf AM Isolation of genomic DNA. Methods Enzymol 1987; 152: 180-3. · DOI
- Pollack JR, Perou CM, Alizadeh AA, et al Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999; 23: 41-6. · DOI
- Pollack JR, Sorlie T, Perou CM, et al Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002; 99: 12963-8. · DOI
- Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes. Exp Cell Res 1997; 235: 245-53. · DOI
- Viallet J, Liu C, Emond J, Tsao MS Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. Exp Cell Res 1994; 212: 36-41. · DOI
- Willey JC, Broussoud A, Sleemi A, et al Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res 1991; 51: 5370-7.
- Zhang L, Liu T, Liu H, Gu C HPV16 E6E7 fragments transform immortalized human bronchial epithelial cells into neoplastic cells[in Chinese]. Zhonghua Bing Li Xue Za Zhi 2000; 29: 350-3.
- Forsyth NR, Evans AP, Shay JW, Wright WE Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell 2003; 2: 235-43. · DOI
- Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 1999; 26: 304-11. · DOI
- Hukku B, Rhim JS Role of chromosome 5 in immortalization and tumorigenesis of human keratinocytes. Cancer Genet Cytogenet 1993; 68: 22-31. · DOI
- Jin Y, Zhang H, Tsao SW, et al Cytogenetic and molecular genetic characterization of immortalized human ovarian surface epithelial cell lines: consistent loss of chromosome 13 and amplification of chromosome 20. Gynecol Oncol 2004; 92: 183-91. · DOI
- Savelieva E, Belair CD, Newton MA, et al 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997; 14: 551-60. · DOI
- Tsao SW, Wong N, Wang X, et al Nonrandom chromosomal imbalances in human ovarian surface epithelial cells immortalized by HPV16–E6E7 viral oncogenes. Cancer Genet Cytogenet 2001; 130: 141-9. · DOI
- Troester MA, Hoadley KA, Sorlie T, et al Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 2004; 64: 4218-26. · DOI
Cited by
Byers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
Self-citationDegradation of AMPK by a Cancer-Specific Ubiquitin Ligase
Pineda, C. T., Ramanathan, S., Fon Tacer, K., Weon, J. L., Potts, M. B., Ou, Y.-H., White, M. A., & Potts, P. R. (2015) · Cell · doi:10.1016/j.cell.2015.01.034 · Cited by 389
Ellis, B. L., Hirsch, M. L., Barker, J. C., Connelly, J. P., Steininger, R. J., & Porteus, M. H. (2013) · Virology Journal · doi:10.1186/1743-422x-10-74 · Cited by 252
Smoking, p53 Mutation, and Lung Cancer
Gibbons, D. L., Byers, L. A., & Kurie, J. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0539 · Cited by 255
Self-citationAnticancer and antiproliferative activity of natural brassinosteroids
Malíková, J., Swaczynová, J., Kolář, Z., & Strnad, M. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2007.07.028 · Cited by 170
KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung
Maeda, Y., Tsuchiya, T., Hao, H., Tompkins, D. H., Xu, Y., Mucenski, M. L., Du, L., Keiser, A. R., Fukazawa, T., Naomoto, Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64048 · Cited by 163
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Kauko, O., O’Connor, C. M., Kulesskiy, E., Sangodkar, J., Aakula, A., Izadmehr, S., Yetukuri, L., Yadav, B., Padzik, A., Laajala, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1093 · Cited by 149
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
McMillan, E. A., Ryu, M.-J., Diep, C. H., Mendiratta, S., Clemenceau, J. R., Vaden, R. M., Kim, J.-H., Motoyaji, T., Covington, K. R., Peyton, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.028 · Cited by 141
Self-citationVelimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2795 · Cited by 131
RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas
Konstantinidou, G., Ramadori, G., Torti, F., Kangasniemi, K., Ramirez, R. E., Cai, Y., Behrens, C., Dellinger, M. T., Brekken, R. A., Wistuba, I. I., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0388 · Cited by 114
Self-citationFucosylation and protein glycosylation create functional receptors for cholera toxin
Wands, A. M., Fujita, A., McCombs, J. E., Cervin, J., Dedic, B., Rodriguez, A. C., Nischan, N., Bond, M. R., Mettlen, M., Trudgian, D. C., et al. (2015) · eLife · doi:10.7554/elife.09545 · Cited by 90
Tang, K.-J., Constanzo, J. D., Venkateswaran, N., Melegari, M., Ilcheva, M., Morales, J. C., Skoulidis, F., Heymach, J. V., Boothman, D. A., & Scaglioni, P. P. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2603 · Cited by 91
O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis
Taparra, K., Wang, H., Malek, R., Lafargue, A., Barbhuiya, M. A., Wang, X., Simons, B. W., Ballew, M., Nugent, K., Groves, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94844 · Cited by 80
Du, L., Schageman, J. J., Irnov, Girard, L., Hammond, S. M., Minna, J. D., Gazdar, A. F., & Pertsemlidis, A. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-75 · Cited by 73
Self-citationChalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
Liu, Y., Bernauer, A. M., Yingling, C. M., & Belinsky, S. A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs142 · Cited by 65
Evangelou, K., Bartkova, J., Kotsinas, A., Pateras, I. S., Liontos, M., Velimezi, G., Kosar, M., Liloglou, T., Trougakos, I. P., Dyrskjot, L., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.76 · Cited by 59
Review of hTERT-Immortalized Cells: How to Assess Immortality and Confirm Identity
Shitova, M., Alpeeva, E., & Vorotelyak, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313054 · Cited by 22
CDDO-Me Protects Normal Lung and Breast Epithelial Cells but Not Cancer Cells from Radiation
El-Ashmawy, M., Delgado, O., Cardentey, A., Wright, W. E., & Shay, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115600 · Cited by 19
Self-citation
Metadata
- Authors
- Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., Milchgrub, S., Smith, A. L., Souza, R. F., Gilbey, L., Zhang, X., Gandia, K., Vaughan, M. B., Wright, W. E., Gazdar, A. F., Shay, J. W., & Minna, J. D.
- Affiliations
- 1Hamon Center for Therapeutic Oncology Research and Departments of
- 9Department of Pathology, Stanford University Medical Center, Stanford, California
- 5Cell Biology, and
- 8Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and
- 6Cardiovascular and Thoracic Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas;
- 4Pathology,
- 2Internal Medicine,
- 7Dallas Veterans Affairs Medical Center, Dallas, Texas;
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9027-9034
- ISSN
- 0008-5472
- 1538-7445
- Cited by
- 607
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review